Mobile Trading

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1798.9516.05 (+0.9 %)
PREV CLOSE ( ) 1782.90
OPEN PRICE ( ) 1783.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 147251
TODAY'S LOW / HIGH ( )1770.75 1805.90
52 WK LOW / HIGH ( )1547.25 1850.95
Quarters
Select year  
( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
155205.4
144783.1
138514
129588.4
Total Expenditure
107259.7
103817.3
97787.8
95339.9
PBIDT (Excl OI)
47945.7
40965.8
40726.2
34248.5
Other Income
7327.6
9003.9
6935
9041.1
Operating Profit
55273.3
49969.7
47661.2
43289.6
Interest
783.6
998.6
748
491.4
Exceptional Items
-4894.8
NA
-8180
-3616.8
PBDT
49594.9
48971.1
38733.2
39181.4
Depreciation
7323.3
7295
7005.5
6637.9
Profit Before Tax
42271.6
41676.1
31727.7
32543.5
Tax
8260.7
10305.2
8701.5
10937.1
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
34010.9
31370.9
23026.2
21606.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
34010.9
31370.9
23026.2
21606.4
Minority Interest
-123.6
-70
-142.4
-40.5
Shares of Associates
-199.2
-121.4
-97.5
-67.1
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
33688.1
31179.5
22786.3
21498.8
Equity Capital
2399.3
2399.3
2399.3
2399.3
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
14.04
12.99
9.49
8.96
Calculated EPS (Annualised)
56.16
51.98
37.98
35.84
No of Public Share Holdings
1092215435
1092200435
1092200435
1092200435
% of Public Share Holdings
45.52
45.52
45.52
45.52
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
30.89
28.29
29.40
26.42
PBIDTM%
35.61
34.51
34.40
33.40
PBDTM%
31.95
33.82
27.96
30.23
PBTM%
27.23
28.78
22.90
25.11
PATM%
21.91
21.66
16.62
16.67
 
Notes
Notes
Notes
Notes

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
  • Cameo Corporate Services Limited
  • #1, Subramanian Building,
  • Club House Road, Chennai-600002.
  • Contact No : 044-40020731
Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
© 2018 Ratnakar Securities Limited. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.